Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MLNR | O43193 | 1/20 | 0.31 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.31 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.31 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.31 |
| ▸ | HTR1A | P08908 | 1/20 | 0.31 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.31 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.31 |
| ▸ | DRD2 | P14416 | 1/20 | 0.31 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.31 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.31 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.31 |
| ▸ | DRD1 | P21728 | 1/20 | 0.31 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.31 |
| ▸ | HTR2A | P28223 | 1/20 | 0.31 |
| ▸ | HTR2C | P28335 | 1/20 | 0.31 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.31 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.31 |
| ▸ | HRH1 | P35367 | 1/20 | 0.31 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.31 |
| ▸ | DRD3 | P35462 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25144859 | 0.89 | DRD1 (0.32) | DRD1HTR2A | |
| SCHEMBL19168826 | 0.79 | PARP14 (0.40) | KCNH2 | |
| SCHEMBL19167217 | 0.77 | BRD4 (0.38) | HTR2C | |
| SCHEMBL19167496 | 0.75 | MAOA (0.33) | — | |
| SCHEMBL13966906 | 0.73 | PDK2 (0.36) | — | |
| SCHEMBL13966908 | 0.73 | ACHE (0.33) | MLNRNR1I2CHRM2ADRB1HTR1A | |
| SCHEMBL19167492 | 0.73 | ALOX5 (0.41) | — | |
| SCHEMBL17614226 | 0.73 | PGR (0.42) | — | |
| SCHEMBL10009931 | 0.73 | DPP4 (0.35) | — | |
| SCHEMBL16801323 | 0.73 | MLNR (0.31) | MLNRNR1I2CHRM2ADRB1HTR1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210359214-A1 | ORGANIC LIGHT-EMITTING DEVICE AND APPARATUS INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2021-11-18 | — | — | US | disclosed |
| US-20090026930-A1 | Aromatic compound, organic light-emitting diode including organic layer including the aromatic compound, and method of manufacturing the organic light-emitting diode | SAMSUNG DISPLAY CO., LTD. (KR) | 2009-01-29 | — | — | US | disclosed |
| US-20090026930-A1 | Aromatic compound, organic light-emitting diode including organic layer including the aromatic compound, and method of manufacturing the organic light-emitting diode | SAMSUNG DISPLAY CO., LTD. (KR) | 2009-01-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090026930-A1 | Aromatic compound, organic light-emitting diode including organic layer including the aromatic compound, and method of manufacturing the organic light-emitting diode | CHRM1, CYP1B1, CHRM2 | MLNR 1308/4885NR1I2 343/4885CHRM2 3/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.